S
Spero Therapeutics (SPRO)
$000.00 0.00% ($0.00)
- Today
- Week
- Month
- Year
- 5 Year
- YTD
getbaraka.com
About Spero Therapeutics (SPRO)
Spero Therapeutics, Inc. is a clinical-stage biopharmaceutical company. The Company is focused on identifying, developing and commercializing novel treatments for MDR bacterial infections. Its lead product candidate, tebipenem HBr (tebipenem pivoxil ... Read more
- USD1.48
- USD1.54
- USD1.40
- USD2.00
- -15.00%
- 104M
- 378.58k
- 239.16k
- 88M
- 0.99
- -16.00%
Stock News
yesterday
KKR Real Estate Finance Trust Inc. Declares Preferred Stock Dividend
Yahoo
yesterday
Universal Logistics Holdings, Inc. Named a 2023 Supplier of the Year by General Motors
Yahoo
yesterday
Carnival Corporation & plc Announces Pricing of €500 Million 5.75% Senior Unsecured Notes Offering for Refinancing and Interest Expense Reduction and Successful Repricing of Senior Secured First Lien Term Loan B Facilities for Interest Expense and Debt Reduction
Yahoo
yesterday
UPDATE 1-Teamsters union files charges against PepsiCo with US labor board
Yahoo
Unlock More Stock Analysis & Reports
Access detailed stock analysis from LSEG including analyst price target estimates.
